Suppr超能文献

口服低相对分子质量透明质酸后在小鼠体内的稳态血浆和组织分布。

Steady state plasma and tissue distribution of low molecular weight hyaluronic acid after oral administration in mice.

机构信息

Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.

SunNutraPharm s.r.l., Spin-Off Company of University of Messina, Messina, Italy.

出版信息

Nat Prod Res. 2024 Feb-Mar;38(5):773-780. doi: 10.1080/14786419.2023.2197598. Epub 2023 Apr 20.

Abstract

The oral administration is probably the most used and largely applicable method, even if absorption across the intestinal epithelium is a limiting factor that can invalidate the achievement of a therapy. The aim of this study was to assess the steady state bioavailability of very low molecular weight hyaluronic acid (vLMW-HA) and its distribution in different districts of mice. Adult female C57BL6/J mice ( = 26) were divided in three groups and orally treated for 7 days with: saline solution (SHAM-HA), high dose of vLMW-HA (5 kDa; 500 mg/kg/day; HD-vLMW-HA), and low dose of vLMW-HA (5 kDa; 100 mg/kg/day; LD-vLMW-HA). HA content was quantified in plasma, skin, bladder, gut, rectum, vagina, and eyes with ELISA assay at the end of treatment. HA level significantly increased after treatment with HD-vLMW-HA in all analyzed tissues and plasma. Therefore, vLMW-HA easy absorption and distribution after the oral intake opens new possibilities for future biomedical applications.

摘要

口服给药可能是最常用且适用范围最广的方法,尽管肠上皮细胞的吸收是一个限制因素,可能会使治疗无效。本研究旨在评估超低分子量透明质酸(vLMW-HA)的稳态生物利用度及其在小鼠不同部位的分布。成年雌性 C57BL6/J 小鼠(n=26)分为三组,连续 7 天口服以下处理:生理盐水(SHAM-HA)、高剂量 vLMW-HA(5 kDa;500 mg/kg/天;HD-vLMW-HA)和低剂量 vLMW-HA(5 kDa;100 mg/kg/天;LD-vLMW-HA)。治疗结束时,通过 ELISA 测定法检测血浆、皮肤、膀胱、肠道、直肠、阴道和眼睛中的 HA 含量。在所有分析的组织和血浆中,HD-vLMW-HA 处理后 HA 水平显著升高。因此,vLMW-HA 经口服摄入后易于吸收和分布,为未来的生物医学应用开辟了新的可能性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验